Bath & Body Works, Inc. (BBWI)
NYSE: BBWI · Real-Time Price · USD
26.50
+0.49 (1.88%)
At close: Oct 17, 2025, 4:00 PM EDT
26.07
-0.43 (-1.62%)
After-hours: Oct 17, 2025, 7:39 PM EDT
Bath & Body Works Stock Forecast
Stock Price Forecast
The 16 analysts that cover Bath & Body Works stock have a consensus rating of "Buy" and an average price target of $39.22, which forecasts a 48.00% increase in the stock price over the next year. The lowest target is $26 and the highest is $52.
Price Target: $39.22 (+48.00%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Bath & Body Works stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Buy | 8 | 8 | 8 | 8 | 8 | 7 |
| Hold | 4 | 4 | 4 | 3 | 3 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 17 | 16 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Maintains $32 → $29 | Hold | Maintains | $32 → $29 | +7.55% | Oct 14, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $26 | Buy → Hold | Downgrades | $26 | -1.89% | Oct 6, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $41 → $40 | Buy | Maintains | $41 → $40 | +50.94% | Sep 12, 2025 |
| UBS | UBS | Hold Maintains $36 → $32 | Hold | Maintains | $36 → $32 | +20.75% | Aug 29, 2025 |
| Barclays | Barclays | Hold Maintains $30 → $32 | Hold | Maintains | $30 → $32 | +20.75% | Aug 29, 2025 |
Financial Forecast
Revenue This Year
7.62B
from 7.31B
Increased by 4.22%
Revenue Next Year
7.84B
from 7.62B
Increased by 2.98%
EPS This Year
3.56
from 3.61
Decreased by -1.43%
EPS Next Year
3.88
from 3.56
Increased by 8.96%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 7.9B | 8.2B | |||
| Avg | 7.6B | 7.8B | |||
| Low | 7.3B | 7.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 7.7% | 7.8% | |||
| Avg | 4.2% | 3.0% | |||
| Low | -0.4% | -2.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.73 | 4.14 | |||
| Avg | 3.56 | 3.88 | |||
| Low | 3.36 | 3.53 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.3% | 16.3% | |||
| Avg | -1.4% | 9.0% | |||
| Low | -6.9% | -0.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.